3-methoxymorphinan has been researched along with Endotoxemia in 1 studies
3-methoxymorphinan: dextromethorphan metabolite; RN & N1 from 9th CI Form Index; RN given refers to cpd without isomeric designation; structure in first source
Endotoxemia: A condition characterized by the presence of ENDOTOXINS in the blood. On lysis, the outer cell wall of gram-negative bacteria enters the systemic circulation and initiates a pathophysiologic cascade of pro-inflammatory mediators.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsai, WH | 1 |
| Cheng, PY | 1 |
| Lee, YM | 1 |
| Chiu, MC | 1 |
| Jiau, SS | 1 |
| Wu, ES | 1 |
| Yen, MH | 1 |
1 other study available for 3-methoxymorphinan and Endotoxemia
| Article | Year |
|---|---|
Anti-inflammatory effects of LK-3, on LPS-induced sepsis in rats.
Topics: Animals; Anti-Inflammatory Agents; Blood Pressure; Dextromethorphan; Endotoxemia; Heart Rate; Lipopo | 2008 |